Global IVD Market, 2025 to 2030: Segment Growth, Geographic Opportunities, and Strategic Market Trends

Kalorama | On-Demand Webinar | July 2026

The IVD market is still growing, but growth is shifting. Where is it moving next?

In this free on-demand briefing, Kalorama Information’s Mike Tice, Justin Saeks and Daniel Granderson walk through key findings from The Worldwide Market for IVD Tests, 19th Edition. In 40-plus minutes, you’ll see how the market grew to $115.6 billion in 2025, why growth is normalizing toward $150.4 billion by 2030, and which segments, regions and companies will drive the next five years.

You’ll learn:

• 2025 market size and the five-year outlook: $115.6 billion growing at a 5.4% CAGR to $150.4 billion by 2030
• Which of more than 20 IVD segments are growing at double digits, led by continuous glucose monitoring, molecular oncology, molecular HPV and direct-to-consumer genetic testing
• Geographic opportunities, with a spotlight on Asia Pacific and South Korea’s 6.9% CAGR
• Key market trends, from MRD-driven molecular oncology to multiplex testing beyond respiratory
• Competitive dynamics: how the top 20 companies, with $92 billion in 2025 and about 80% of the market, use M&A and partnerships

Access Includes: 🎬 On-Demand Recording 📊 Webinar Deck / Slides 📄 White Paper